11C-SB207145, 11C-DASB
C24-41
Phase 3 small_molecule active
Quick answer
11C-SB207145, 11C-DASB for Parkinson's disease, Prodromal phase of Parkinson's disease is a Phase 3 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- Parkinson's disease, Prodromal phase of Parkinson's disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active